|
|
ERRATUM |
|
Year : 2019 | Volume
: 13
| Issue : 3 | Page : 55-57 |
|
Erratum: Comparative effects of human albumin versus modern hydroxyethyl starch in living-donor renal transplant
Date of Web Publication | 27-Feb-2020 |
Correspondence Address:
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1687-9090.279645
How to cite this article: . Erratum: Comparative effects of human albumin versus modern hydroxyethyl starch in living-donor renal transplant. Egypt J Cardiothorac Anesth 2019;13:55-7 |
How to cite this URL: . Erratum: Comparative effects of human albumin versus modern hydroxyethyl starch in living-donor renal transplant. Egypt J Cardiothorac Anesth [serial online] 2019 [cited 2021 Apr 18];13:55-7. Available from: http://www.ejca.eg.net/text.asp?2019/13/3/55/279645 |
In the article titled “Comparative effects of human albumin versus modern hydroxyethyl starch in living-donor renal transplant”, published on pages 23-29, Issue 2, Volume 13 of The Egyptian Journal of Cardiothoracic Anesthesia[1], The whole Results Section has been incorrectly published. The correct Results Section is mentioned below:
Results | |  |
In all,120 patients, meeting our inclusion criteria, were enrolled in the study and were randomly allocated into one of the two groups: Tetraspan (FRESENIUS KABI, Bad Homburg, Germany) (HES) group and ALB group. All 120 enrolled patients completed the study.
Demographic data (age, sex, BMI, and ASA class) ([Table 1]) and the preoperative laboratory work were similar in both groups. The intraoperative graft characteristics (cold ischemic time, warm ischemic time. and the total operative time) were also comparable in the two groups ([Table 2]).
There was no statistical difference in the study colloid volume required intraoperatively for each group (700±128.65 ml in the HES group vs. 728.33±139.38 ml in the ALB group, P=0.417) as well as concerning the intraoperative blood loss ([Table 2]). The use of crystalloids, packed red blood cells (RBCs) and fresh frozen plasma and the diuretics consumption did not vary in between the two groups.
The hemodynamic variables remained stable and did not show a significant difference between the study groups at any of the measuring points, in terms of the mean BP and the CVP ([Table 3] and [Table 4]).
Start of diuresis was immediate in all patients except for four (6.7%) in the HES group and six (10%) in the ALB group. In respect of later graft function, it was evaluated using postoperative BUN, CrCl, creatinine (Cr) and 24-h urine volume. We did not observe differences in all these parameters throughout the entire study period being measured on the first, second, third, and seventh post-transplant days, irrespective of whether Tetraspan or ALB was infused ([Table 5] and [Table 6]) together with ([Figure 1] and [Figure 2]). Regarding the coagulopathic effect, both groups showed comparable results in their postcolloid infusion INR ([Table 7]).
Dialysis was needed for six patients in the ALB group and four patients in the HES group (P=1). No cases suffering a graft rejection episode were reported for the 1-week duration of the study following transplantation.
References | |  |
1. | Seif NE, Mohammed AK. Comparative effects of human albumin versus modern hydroxyethyl starch in living-donor renal transplant. Egypt J Cardiothorac Anesth 2019; 13:23–9. [Full text] |
[Figure 1], [Figure 2]
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5], [Table 6], [Table 7]
|